Market Access: Pharma

Health Economics and Outcomes Research (HEOR) Strategy

Industry-leading research and strategy development

Alira Health provides a range of research and strategy solutions designed for commercial market success. We provide a host of advisory services, including
  • HEOR and evidence strategies
  • Reviews of global cost-effectiveness models and country adaptations
  • Budget impact and cost-effectiveness models
  • Patient-reported outcomes (PRO) strategies
  • Competitor analyses

Why choose Alira Health?

As your partner, we’ll work closely with you to uncover opportunities across the pharma industry, accelerate innovation, and deliver tomorrow’s standard of care. You’ll benefit from our:

  • Access to a diverse

    integrated team with deep industry expertise

  • Close collaboration

    with our regulatory and clinical

  • Specific, local insights

    as part of your larger, global strategy—a benefit of having market access teams in both the EU and U.S.

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Jean-François Ricci
Jean-François Ricci
Executive Vice President, Global Market Access
Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle.

Related News

Market Access
Multimedia January 19, 2022
Alira Health’s Transformation Talks: Early Access Programs: Why and How?
Listen to this episode of "Transformation Talks" to discover the benefits and challenges of implementing EAPs from both the industry and payer perspectives and the main recommendations(...)
M&A MedTech Pharma
News January 13, 2022
Alira Health Secures an Additional $40M in Funding, Led by Creadev
We announced today the closing of an equity financing in which it raised gross proceeds of US$40 million. We intend to use the funds to invest in solutions that actively engage patients(...)
Pharma
Events December 23, 2021
Event: Presentation of the 2021 BioRegion Report
We are thrilled to announce that Alira Health has contributed to the BioRegion Report 2021,
Clinical Pharma
Publications December 21, 2021
An Insider Look at Vaccines: Yesterday, Today, Tomorrow
The COVID-19 pandemic has put vaccines in the spotlight. The pandemic has given the industry a considerable boost, and with lessons learned during the development and roll-out(...)
Market Access
Multimedia December 16, 2021
Alira Health’s Transformation Talks: Navigating the Vaccines’ Renaissance
Tune into this episode of "Transformation Talks" to learn more about the the ups and downs of the vaccine industry, how the COVID pandemic has transformed it, and what is coming up next. 
Advanced Analytics Digital Health Pharma Research & Development
Publications December 10, 2021
Leveraging Data Intelligence for Effective Opportunity Screening and Prioritization in Drug Discovery
Our biotech client needed an innovative, effective way to identify which binding sites and therapeutic indications they should target for the development of new therapeutic agents for(...)
Market Access
Publications December 3, 2021
White Paper: Enhancing Patient Access with Early Access Programs
Pharmaceutical companies are facing an increasing demand from physicians for Early Access Programs (EAPs) and are willing to make their innovative medicines available to patients with(...)
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.